The next social challenge to public health: the information environment.pptx
Modern classification of lymphomas (2010) VEAB presentation
1. Modern classification of lymphomas András Matolcsy 1st. Department of Pathology and Experimental Cancer Research Semmelweis University Budapest Hungary
2.
3.
4.
5. Kiel classification (1974, 1988) Low grade High grade B-cell B-CLL Centroblastoma Immunocytoma B immunoblastoma Centrocytoma B anaplastic large cell Centrocytic-centroblastic Burkitt’s lymphoma T-cell T-CLL T lymphoblastoma T zone lymphoma T immunoblastoma Lymphoepitheloid T anaplastic large cell Angioimmunoblastic Pleomorphic
9. The role of basic science in lymphoma classification
10. B-cell ontogeny and lymphomagenesis C entroblast Plasma cell Marginal zone B cell Naive B cell Centrocyte Ag-experienced mature B cell Antigene Plasmablast Mantle zone B cell Memory B cell Bone marrow Interfollicular area Follicular area Perifollicular area Peripheral blood Extranodal tissues Progenitor B cell Follicular lymphoma CLL/SLL Precursor ALL/LB DLBCL CG-type Burkitt’s lymphoma DLBCL ABC-type Mantle zone lymphoma Margianal zone lymphoma Multiple myeloma FDC Precursor neoplasms Pre-GC neoplasms GC neoplasms Post-GC neoplasms
11. Lymphomas associated with infectious agents Nasal, cutaneous and systemic NK/T-cell lymphomas EBV Adult T-cell leukemia/lymphoma HTLV1 Marginal zone lymphomas H pylori, B burgdorferi, C jejuni, Hepatitis C Primary effusion lymphoma, HHV-8/ KSHV LBCL associated with multicentric C astlemann disease HHV-8/ KSHV Plasmablastic, Burkitt, DLBCL, CHL EBV (subset of cases) Lymphomas with deregulation of apoptosis and survival pathways Follicular lymphoma BCL2/IGH@ MALT lymphomas API2/MALT1 and variants Lymphomas with deregulation of the cell cycle Mantle cell lymphoma CCND1/IGH@ Burkitt’s lymphoma MYC/IGH@ and variants Lymphomas with deregulation of cell signaling or transcriptional regulation Anaplastic large cell lymphoma NPM/ALK and variants Diffuse large B-cell lymphomas BCL6, NFB, Stat6 Lymphomas associated with host susceptibility factors, congenital or acquired Enteropathy-associated T-cell lymphoma Genetics, gliadin allergy Extranodal and systemic EBV T/NK cell lymphomas Genetics, host response to EBV Hepatosplenic T-cell lymphoma I mmunosuppression Lymphomatoid granulomatosis Partial immune dysfunction and EBV Burkitt lymphoma Polyclonal B-cell activation (malaria, HIV) Posttransplant lymphoproliferative ndisorders Iatrogenic immunosuppression Pathogenetic disease-oriented approach to lymphoma classification
14. Anatomic sites in classification of lymphomas „ The clinicopathological entities”
15. DLBCL – morphologic variants centroblastic immunoblasic anaplastic T cell/histiocyte rich Kiel classification (1974, 1988) Centroblastoma B-immunoblastoma B-anaplastic large cell Working formulation (1982) Diffuse large cell Diffuse large cell immunoblastic REAL (1994) Diffuse large B-cell lymphoma
16. DLBCL 2001-2008 WHO classification WHO (2001) Diffuse large B-cell lymphoma Morphologic variants Centroblastic Immunoblastic Anaplastic T cell/histiocyte-rich Clinicopathologic entities Primary mediastinal large B-cell lymphoma Intravascular large B-cell lymphoma Primary effusion lymphoma Lymphomatoid granulomatosis WHO (2008) Diffuse large B-cell lymphoma Morphologic variants Centroblastic Immunoblastic Anaplastic Rare variants (spindle cell, myxoid ect.) Clinicopathologic entities Primary mediastinal large B-cell lymphoma Intravascular large B-cell lymphoma Primary effusion lymphoma Lymphomatoid granulomatosis T cell/histiocyte-rich DLBCL associated with chronic inflammation ALK + large B-cell lymphoma Plasmablastic lymphoma DLBCL arising in HHV8 + Castleman Primary DLBCL of the CNS Primary cutaneous DLBCL, leg type EBV + DLBCL of the elderly
17. Early events in lymphoid neoplasia „Proliferations of uncertain malignant potencial”
22. „ In situ” mantle cell lymphoma In-situ mantle cell lymphoma—a report of two cases N Aqel, F Barker, K Patel and K N Naresh Histopathology 2008; 52:256 Cyclin D1 Cyclin D1
23. Early gastric extranodal marginal zone (MALT) lymphoma CD20 t(11;18)(q21;q21) - API2 / MALT1 t(1;14)(p22;q32) - BCL10 / IgH ) +3 +18 Helicobacter ass. gastritis MALT lymphoma DLBCL HE HE HE Giemsa CD20 CD20